MannKind Corporation Posters Win Awards from International Pharmaceutical Aerosol Consortium on Regulation and Science

DANBURY, Conn.--(BUSINESS WIRE)--MannKind Corporation (Nasdaq: MNKD) today announced that it was awarded two poster awards at the 2011 conference of the International Pharmaceutical Aerosol Consortium on Regulation and Science (IPAC-RS), held March 29-31 in Rockville, Maryland. IPAC-RS is an international association of companies that develop, manufacture or market orally inhaled and nasal drug products for local and systemic treatment of a variety of debilitating diseases such as asthma, chronic obstructive pulmonary disease and diabetes.

MORE ON THIS TOPIC